MC-002434 identified as prototype efflux pump inhibitor for potentiating levofloxacin activity March 27, 2000
Enrollment completed in European phase III trial of platelet pathogen inactivation system March 23, 2000
Antimicrobial mutilin derivatives for Gram-positive, Gram-negative and mycoplasmal infections March 21, 2000